Search

Author/Creator Castro-Borrero, Wanda

1. Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis. (31st August 2021)

Authors:
Gray-Roncal, Karla; Fitzgerald, Kathryn C.; Ryerson, Lana Zhovtis; Charvet, Leigh; Cassard, Sandra D.; Naismith, Robert; Ontaneda, Daniel; Mahajan, Kedar; Castro-Borrero, Wanda; Mowry, Ellen M.
Journal:
Neurology
Issue:
Volume 97:Number 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Circulating lymphocyte levels and relationship with infection status in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta. (November 2018)

Authors:
Giovannoni, Gavin; Wiendl, Heinz; Turner, Benjamin; Umans, Kimberly; Mokliatchouk, Oksana; Castro-Borrero, Wanda; Greenberg, Steven J; McCroskery, Peter; Giannattasio, Giorgio
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 13(2018)
Page Start:
1725
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis. Issue 7 (July 2016)

Authors:
Krueger, James; Kircik, Leon; Hougeir, Firas; Friedman, Adam; You, Xiaojun; Lucas, Nisha; Greenberg, Steven; Sweetser, Marianne; Castro-Borrero, Wanda; McCroskery, Peter; Elkins, Jacob
Journal:
Advances in therapy
Issue:
Volume 33:Issue 7(2016)
Page Start:
1231
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study. (May 2018)

Authors:
Benedict, Ralph HB; Cohan, Stanley; Lynch, Sharon G; Riester, Katherine; Wang, Ping; Castro-Borrero, Wanda; Elkins, Jacob; Sabatella, Guido
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 6(2018)
Page Start:
795
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination. (February 2021)

Authors:
Kappos, Ludwig; Cohan, Stanley; Arnold, Douglas L.; Robinson, Randy R.; Holman, Joan; Fam, Sami; Parks, Becky; Xiao, Shan; Castro-Borrero, Wanda
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗